DOI QR코드

DOI QR Code

Adipocyte-Related Genes and Transcription Factors were affected by Ganoderma lucidum during 3T3-L1 Differentiation

지방세포 분화중인 3T3-L1 세포에서 영지추출물에 의한 지방관련 유전자와 전사인자의 발현 조절

  • Lee, Chae-Woo (Dept. of Acupuncture & Moxibustion College of Oriental Medicine, Dong-Eui University) ;
  • Yoon, Hyun-Min (Dept. of Acupuncture & Moxibustion College of Oriental Medicine, Dong-Eui University) ;
  • Kang, Kyung-Hwa (Department of Oriental Physiology, College of Oriental Medicine, Dongeui University)
  • 이채우 (동의대학교 한의과대학 침구학교실) ;
  • 윤현민 (동의대학교 한의과대학 침구학교실) ;
  • 강경화 (동의대학교 한의과대학 생리학교실)
  • Published : 2009.06.30

Abstract

In this study, the effects of Ganoderma lucidum (GL) on fat metabolism were performed in 3T3-L1 adipocytes. The effects of GL on 3T3-L1 preadipocytes differentiation were also examined. Our results showed that GL decreased the TG content by ORO staining. To elucidate the mechanism of the effects of GL on lowering TG content in 3T3-L1 adipocytes, we examined whether GL modulate the expressions of transcription factors and adipokines related to control of energy expenditure process because adipokines regulate adipocyte mass and increased expenditure may consume much TG in adipocytes. As a result, the expression of C/$EBP{\beta}$, C/$EBP{\delta}$, C/$EBP{\alpha}$, and $PPAR{\gamma}$, genes, which induce the adipose differentiation and adipose-specific FAS, aP2, and adipsin genes, which compose fat formation were decreased. In addition, GL increased the expression of leptin, UCP2, adiponectin in 3T3-L1 adipocytes, resulting in energy homeostasis. In conclusion, GL could regulate transcript factor related to induction of adipose differentiation and control TG content by up-regulation of adipokines related to fat burn.

Keywords

References

  1. Stein CJ, C.G., The epidemic of obesity. J Clin Endocrinol Metab, 2004. 89: p. 2522-5 https://doi.org/10.1210/jc.2004-0288
  2. Kopelman, P., Obesity as a medical problem. Nature, 2000. 404: p. 635-.43 https://doi.org/10.1038/35007508
  3. Ahima RS, F.J., Adipose tissue as an endocrine organ. Trends Endocrinol Metab., 2000. 11(8): p. 327-32 https://doi.org/10.1016/S1043-2760(00)00301-5
  4. Kim, M., Updates in treating obesity. Korean J Health Psychol., 2004. 9: p. 493-509
  5. Reddy P, C.M., Focus on orlistat: A nonsystemic inhibitor of gastrointestinal lipase for weight reduction in the management of obesity. Formulary, 1998. 33: p. 943-959
  6. Seo, Y., Patent trend of anti-obesity supplmentary food. Food World, 2005. 8: p. 116-122
  7. Lee SZ. Compendium of Materia Medica. 2007, Yeoil. 166-172
  8. Nogami M, I.M., Kubo M, Takahashi M, Kimura H, Matsuike Y., Studies on Ganoderma lucidum. VII. Anti-allergic effect. (2) Yakugaku Zasshi., 1986. 106(7): p. 600-604
  9. Futrakul N, B.M., Patumraj S, Siriviriyakul P, Tosukhowong P, Futrakul P., Treatment of glomerular endothelial dysfunction in steroidresistant nephrosis with Ganoderma lucidum, vitamins C, E and vasodilators. Clin Hemorheol Microcirc., 2003. 29(3-4): p. 205-210
  10. Chen WQ, L.S., Ll HZ, Yang H., Effects of ganoderma lucidum polysaccharides on serum lipids and lipoperoxidation in experimental hyperlipidemic rats. Zhongguo Zhong Yao Za Zhi, 2005. 30(17): p. 1358-1360
  11. Qi G, H.H., Gao Y, Lin Q, Yu GY, Effects of Ganoderma lucidum spores on sialoadenitis of nonobese diabetic mice. Chin Med J (Engl), 2009. 122(5): p. 556-560
  12. Lin, Z.B., Cellular and molecular mechanisms of immuno-modulation by Ganoderma lucidum. J Pharmacol Sci., 2005. 99(2): p. 144-153 https://doi.org/10.1254/jphs.CRJ05008X
  13. Jiang J, G.B., Thyagarajan A, Sliva D, Ganoderic acids suppress growth and invasive behavior of breast cancer cells by modulating AP-1 and NF-kappaB signaling. Int J Mol Med., 2008. 21(5): p. 577-584
  14. Lee DH. Incurable Disease and herbal pharmacopuncture therapy. Journal of Korean pharmacopuncture institute, 2003. 6(1): p. 9-11 https://doi.org/10.3831/KPI.2003.6.1.009
  15. Lee CW, Yoon HM, Kang KH, The effects of Ganoderma lucidum herba pharmacopuncture on 3T3-L1 preadipocyte differentiation. Journal of Korean pharmacopuncture institute, 2008. 11(3): p. 47-53 https://doi.org/10.3831/KPI.2008.11.3.047
  16. MacDougald OA, H.C., Fan H, Lane MD Regulated expression of the obese gene product (leptin) in white adipose tissue and 3T3-L1 adipocytes. Proc Natl Acad Sci USA, 1995. 92(20): p. 9034-9037 https://doi.org/10.1073/pnas.92.20.9034
  17. Klaus, S., Adipose tissue as a regulator of energy balance. Curr Drug Targets., 2004. 5(3): p. 241-50 https://doi.org/10.2174/1389450043490523
  18. Koldovsky O, D.M., Drahota Z, Hahn P., Developmental aspects of lipid metabolism. Physiol Res. , 1995. 44(6): p. 353-6
  19. Gregoire FM, S.C., Sul HS, Understanding adipocyte differentiation. Physiol Rev., 1998. 78: p. 783-809
  20. Camp HS, R.D., Leff T., Adipogenesis and fatcell function in obesity and diabetes. Trends Mol Med. , 2002. 8(9): p. 442-447 https://doi.org/10.1016/S1471-4914(02)02396-1
  21. Long SD, P.P., Lipid mediators of insulin resistance: ceramide signalling down-regulates GLUT4 gene transcription in 3T3-L1 adipocytes. Biochem J., 1996. 319: p. 179-184
  22. Hwang CS, L.T., Mandrup S, Lane MD, Adipocyte differentiation and leptin expression. Annu Rev Cell Dev Biol., 1997. 13: p. 231-259 https://doi.org/10.1146/annurev.cellbio.13.1.231
  23. Ceddia RB, W.W.J., Lima FB, Flandin P, Curi R, Giacobino JP, Leptin stimulates uncoupling protein-2 mRNA expression and Krebs cycle activity and inhibits lipid synthesis in isolated rat white adipocytes. Eur J Biochem., 2000. 267(19): p. 5952-5958 https://doi.org/10.1046/j.1432-1327.2000.01664.x
  24. Berg AH, C.T., Du X, Brownlee M, Scherer PE., The adipocyte-secreted protein Acrp30 enhances hepatic insulin action. Nat Med., 2001. 7(8): p. 945-953 https://doi.org/10.1038/90992
  25. Antuna-Puente B, F.B., Fellahi S, Bastard JP., Adipokines: the missing link between insulin resistance and obesity. Diabetes Metab., 2008. 34(1): p. 2-11 https://doi.org/10.1016/j.diabet.2007.09.004

Cited by

  1. The Effects ofGanoderma LucidumPharmacopuncture and Moxibustion (Wang-tteum) on Abdominal Obesity: Case Report vol.16, pp.1, 2016, https://doi.org/10.15429/jkomor.2016.16.1.64